1Rovira M, Cervantes F, Nomdedeu B, Rozman C (1990) Chronic neutrophilic leukaemia preceding for seven years the development of multiple myeloma. Acta Haematol 83: 94-95.

2Prosper F, Borbolla JR, Rifón J, Cuesta B, Fernandez J, et al. (1992) Coexistence of essential thrombocythemia and multiple myeloma. Ann Hematol 65: 103-105.

3Arlen PM, Goldkland GA (1995) Multiple myeloma after treatment of essential thrombocythemia. South Med J 88: 79-81.

4Boneva R, Gercheva L, Todorov V, Dimitrova B (1996) Development of multiple myeloma in 2 patients with chronic pyelonephritis and long-term hemodialysis treatment. Nephron 73: 124.

5Wickenhauser C, Borchmann P, Diehl V, Scharffetter-Kochanek K (1999) Development of IgG lambda multiple myeloma in a patient with cutaneous CD30+ anaplastic T-cell lymphoma. Leuk Lymphoma 35: 201-206.

6Dorn GW, Baldwin JG Jr. (1984) Rapid development of myeloma in a patient with Hodgkin's disease. J S C Med Assoc 80: 599-600.

7Yeh GK, Axelrod MR (1979) Tumores rari et inusitati. Development of multiple myeloma in long term survivors of breast cancer. Clin Oncol 5: 175-177.

8Drasin H, Blume MR, Rosenbaum EH, Klein HZ (1979) Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis. Cancer 44: 215-220.

9Grudeva-Popova J, Nenova I, Spasova M, Yaneva M, Beleva E, et al. (2013) Multiple myeloma in association with second malignancy. JBUON 18: 448-452.

10Keklik M, Sivgin S, Deniz K, Karaca H, Kontas O, et al. (2013) Coincidence of three solid tumors in a patient with multiple Myeloma. Chin MedJ 126: 1186-1187.

11Garipidou V, Vakalopoulou S, Tziomalos K (2005) Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia After Treatment with Imatinib Mesylate. The Oncologist 10: 457-458.

12Michael M, Antoniades M, Lemesiou E, Papaminas N, Melanthiou F (2009) Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia While on Treatment with Imatinib Mesylate for 65 Months. The Oncologist 14: 1198-1200.

13O.Selroos and A. van Assendelft (1977) Thrombocythaemia and Multiple Myeloma A Report on Two Cases. Acts Med Scand 201: 243-247.

14Lewis MJ, Oelbaum MH, Coleman M, Allen S (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. British journal of haematology 63: 173-180.

15RH Kough, AZ Makary (1978) Chronic lymphocytic leukemia (CLL) terminating in multiple myeloma: report of two cases. Blood 52: 532-536

16Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, et al. (1998) Coexistence of Chronic Myelogenous Leukemia and Multiple Myeloma Case Report and Review of the Literature. Acta Haematol 99: 221–223

17Zoumbos NC, Chrysanthopoulos C, Starakis J, Kapatais-Zoumbos K (1987) Kappa light chain myeloma developing in a patient with chronic neutrophilic leukaemia. British journal of haematology 65: 504-505.

18Lewis MJ, Oelbaum MH, Coleman M, Allen S (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. British journal of haematology 63: 173-180.

19Shuster M, Causing W C (1971) Chronic lymphatic leukemia and lymphosarcoma terminating in multiple myeloma. The Journal of the Medical Society of New Jersey 68: 365-368.

20Hashimoto S, Kawano E, Hirasawa A, Morio S, Aotuka N, et al. (1992) Multiple myeloma in a patient in remission from malignant lymphoma. [Rinshō ketsueki] The Japanese journal of clinical hematology 33: 671-676.

21Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, et al. (1998) Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature. Acta haematologica 99: 221-223.

22Raz I, Polliack A (1984) Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer 153: 83-85.

23Prósper F, Borbolla JR, Rifón J, Cuesta B, Fernández J, et al. (1992) Coexistence of essential thrombocythemia and multiple myeloma. Annals of hematology 65: 103-105.

24Kough RH, Makary AZ (1978) Chronic lymphocytic leukemia(CLL) terminating in multiple myeloma: report of two cases. Blood 52: 532-536.

1Rovira M, Cervantes F, Nomdedeu B, Rozman C (1990) Chronic neutrophilic leukaemia preceding for seven years the development of multiple myeloma. Acta Haematol 83: 94-95.

2Prosper F, Borbolla JR, Rifón J, Cuesta B, Fernandez J, et al. (1992) Coexistence of essential thrombocythemia and multiple myeloma. Ann Hematol 65: 103-105.

3Arlen PM, Goldkland GA (1995) Multiple myeloma after treatment of essential thrombocythemia. South Med J 88: 79-81.

4Boneva R, Gercheva L, Todorov V, Dimitrova B (1996) Development of multiple myeloma in 2 patients with chronic pyelonephritis and long-term hemodialysis treatment. Nephron 73: 124.

5Wickenhauser C, Borchmann P, Diehl V, Scharffetter-Kochanek K (1999) Development of IgG lambda multiple myeloma in a patient with cutaneous CD30+ anaplastic T-cell lymphoma. Leuk Lymphoma 35: 201-206.

6Dorn GW, Baldwin JG Jr. (1984) Rapid development of myeloma in a patient with Hodgkin's disease. J S C Med Assoc 80: 599-600.

7Yeh GK, Axelrod MR (1979) Tumores rari et inusitati. Development of multiple myeloma in long term survivors of breast cancer. Clin Oncol 5: 175-177.

8Drasin H, Blume MR, Rosenbaum EH, Klein HZ (1979) Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis. Cancer 44: 215-220.

9Grudeva-Popova J, Nenova I, Spasova M, Yaneva M, Beleva E, et al. (2013) Multiple myeloma in association with second malignancy. JBUON 18: 448-452.

10Keklik M, Sivgin S, Deniz K, Karaca H, Kontas O, et al. (2013) Coincidence of three solid tumors in a patient with multiple Myeloma. Chin MedJ 126: 1186-1187.

11Garipidou V, Vakalopoulou S, Tziomalos K (2005) Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia After Treatment with Imatinib Mesylate. The Oncologist 10: 457-458.

12Michael M, Antoniades M, Lemesiou E, Papaminas N, Melanthiou F (2009) Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia While on Treatment with Imatinib Mesylate for 65 Months. The Oncologist 14: 1198-1200.

13O.Selroos and A. van Assendelft (1977) Thrombocythaemia and Multiple Myeloma A Report on Two Cases. Acts Med Scand 201: 243-247.

14Lewis MJ, Oelbaum MH, Coleman M, Allen S (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. British journal of haematology 63: 173-180.

15RH Kough, AZ Makary (1978) Chronic lymphocytic leukemia (CLL) terminating in multiple myeloma: report of two cases. Blood 52: 532-536

16Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, et al. (1998) Coexistence of Chronic Myelogenous Leukemia and Multiple Myeloma Case Report and Review of the Literature. Acta Haematol 99: 221–223

17Zoumbos NC, Chrysanthopoulos C, Starakis J, Kapatais-Zoumbos K (1987) Kappa light chain myeloma developing in a patient with chronic neutrophilic leukaemia. British journal of haematology 65: 504-505.

18Lewis MJ, Oelbaum MH, Coleman M, Allen S (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. British journal of haematology 63: 173-180.

19Shuster M, Causing W C (1971) Chronic lymphatic leukemia and lymphosarcoma terminating in multiple myeloma. The Journal of the Medical Society of New Jersey 68: 365-368.

20Hashimoto S, Kawano E, Hirasawa A, Morio S, Aotuka N, et al. (1992) Multiple myeloma in a patient in remission from malignant lymphoma. [Rinshō ketsueki] The Japanese journal of clinical hematology 33: 671-676.

21Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, et al. (1998) Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature. Acta haematologica 99: 221-223.

22Raz I, Polliack A (1984) Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer 153: 83-85.

23Prósper F, Borbolla JR, Rifón J, Cuesta B, Fernández J, et al. (1992) Coexistence of essential thrombocythemia and multiple myeloma. Annals of hematology 65: 103-105.

1Rovira M, Cervantes F, Nomdedeu B, Rozman C (1990) Chronic neutrophilic leukaemia preceding for seven years the development of multiple myeloma. Acta Haematol 83: 94-95.

2Prosper F, Borbolla JR, Rifón J, Cuesta B, Fernandez J, et al. (1992) Coexistence of essential thrombocythemia and multiple myeloma. Ann Hematol 65: 103-105.

3Arlen PM, Goldkland GA (1995) Multiple myeloma after treatment of essential thrombocythemia. South Med J 88: 79-81.

4Boneva R, Gercheva L, Todorov V, Dimitrova B (1996) Development of multiple myeloma in 2 patients with chronic pyelonephritis and long-term hemodialysis treatment. Nephron 73: 124.

5Wickenhauser C, Borchmann P, Diehl V, Scharffetter-Kochanek K (1999) Development of IgG lambda multiple myeloma in a patient with cutaneous CD30+ anaplastic T-cell lymphoma. Leuk Lymphoma 35: 201-206.

6Dorn GW, Baldwin JG Jr. (1984) Rapid development of myeloma in a patient with Hodgkin's disease. J S C Med Assoc 80: 599-600.

7Yeh GK, Axelrod MR (1979) Tumores rari et inusitati. Development of multiple myeloma in long term survivors of breast cancer. Clin Oncol 5: 175-177.

8Drasin H, Blume MR, Rosenbaum EH, Klein HZ (1979) Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis. Cancer 44: 215-220.

9Grudeva-Popova J, Nenova I, Spasova M, Yaneva M, Beleva E, et al. (2013) Multiple myeloma in association with second malignancy. JBUON 18: 448-452.

10Keklik M, Sivgin S, Deniz K, Karaca H, Kontas O, et al. (2013) Coincidence of three solid tumors in a patient with multiple Myeloma. Chin MedJ 126: 1186-1187.

11Garipidou V, Vakalopoulou S, Tziomalos K (2005) Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia After Treatment with Imatinib Mesylate. The Oncologist 10: 457-458.

12Michael M, Antoniades M, Lemesiou E, Papaminas N, Melanthiou F (2009) Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia While on Treatment with Imatinib Mesylate for 65 Months. The Oncologist 14: 1198-1200.

13O.Selroos and A. van Assendelft (1977) Thrombocythaemia and Multiple Myeloma A Report on Two Cases. Acts Med Scand 201: 243-247.

14Lewis MJ, Oelbaum MH, Coleman M, Allen S (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. British journal of haematology 63: 173-180.

15RH Kough, AZ Makary (1978) Chronic lymphocytic leukemia (CLL) terminating in multiple myeloma: report of two cases. Blood 52: 532-536

16Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, et al. (1998) Coexistence of Chronic Myelogenous Leukemia and Multiple Myeloma Case Report and Review of the Literature. Acta Haematol 99: 221–223

17Zoumbos NC, Chrysanthopoulos C, Starakis J, Kapatais-Zoumbos K (1987) Kappa light chain myeloma developing in a patient with chronic neutrophilic leukaemia. British journal of haematology 65: 504-505.

18Lewis MJ, Oelbaum MH, Coleman M, Allen S (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. British journal of haematology 63: 173-180.

19Shuster M, Causing W C (1971) Chronic lymphatic leukemia and lymphosarcoma terminating in multiple myeloma. The Journal of the Medical Society of New Jersey 68: 365-368.

20Hashimoto S, Kawano E, Hirasawa A, Morio S, Aotuka N, et al. (1992) Multiple myeloma in a patient in remission from malignant lymphoma. [Rinshō ketsueki] The Japanese journal of clinical hematology 33: 671-676.

21Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, et al. (1998) Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature. Acta haematologica 99: 221-223.

22Raz I, Polliack A (1984) Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous presentation in three patients. Cancer 153: 83-85.

23Prósper F, Borbolla JR, Rifón J, Cuesta B, Fernández J, et al. (1992) Coexistence of essential thrombocythemia and multiple myeloma. Annals of hematology 65: 103-105.

24Kough RH, Makary AZ (1978) Chronic lymphocytic leukemia(CLL) terminating in multiple myeloma: report of two cases. Blood 52: 532-536.

25Aksoy M, Erdem S, Dinçol G, Kutlar A, Bakioğlu I, et al. (1984) Clinical observations showing the role of some factors in the etiology of multiple myeloma. A study in 7 patients. Acta haematologica 71: 116-120

26Field-Smith A, Morgan GJ, Davies FE (2005) Bortezomib (Velcade™) in the Treatment of Multiple Myeloma. Oncol 3: 19-22.

27Qi W, White MC, Choi W, Guo C, Dinney C, et al. (2013) Inhibition of inducible heat shock protein-70 (hsp72) enhances bortezomib-induced cell death in human bladder cancer cells. PLoS One 8: e69509.

28Papageorgiou A, Kamat A, Benedict WF, Dinney C, McConkey DJ (2006) Combination therapy with IFN-alpha plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells. Mol Cancer Ther 5: 3032-3041.

29Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, et al. (2005) Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells. Cancer Res 65: 4902-4908.

30Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, et al. (2004) The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. Mol Cancer Ther 3: 279-290.

27Qi W, White MC, Choi W, Guo C, Dinney C, et al. (2013) Inhibition of inducible heat shock protein-70 (hsp72) enhances bortezomib-induced cell death in human bladder cancer cells. PLoS One 8: e69509.

28Papageorgiou A, Kamat A, Benedict WF, Dinney C, McConkey DJ (2006) Combination therapy with IFN-alpha plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells. Mol Cancer Ther 5: 3032-3041.

29Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, et al. (2005) Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells. Cancer Res 65: 4902-4908.

30Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, et al. (2004) The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. Mol Cancer Ther 3: 279-290.